Life Course Health for Women & Children and Reproductive Health

Background

A life-course approach to health encompasses strategies at different stages across individuals’ lives that optimize their health and functional ability (taking into account the interdependence of individual, social, environmental, temporal and intergenerational factors), thereby enabling the well-being for all at all ages. With these in mind, the “Life Course Health” training program will address many challenges facing China, such as women with high-risk pregnancy due to the opening of the “Two Child” policy, increasing infertility and demand for assistant pregnancy, obesity and behavior issues among children and adolescents, aging society, increased demand for high quality healthcare service, and advanced science and technologies for diagnostic and treatment practice, negative and positive impact of social, behavior and nutrition, environment pollution on pregnancy and early child development as well as adulthood risks of noncommunicable diseases.

 

The Life Course Health for Women & Children and Reproductive Health Program prepares participants with a comprehensive perspective of healthcare for women and children in the U.S. and China. The program covers reproductive medicine, prenatal and postnatal care to pediatric and adolescent care. It also touches relevant topics of genomic, clinical, and lifestyle factors, as well as leadership and quality improvement.

 

 

Who Should Attend

Chief Physicians in reproductive medicine, IVF, obstetrics, gynecology, pediatrics and related fields are the potential participants of the program. Other related clinical experts and managerial personals are also encouraged to apply.

 

 

Key Benefits

Participants are expected to learn about the following aspects in life course health for women and children: 

 

Overview

  • Women’s and children’s life course health in the U.S.

  • Leadership and management skills

  • Maintaining healthcare quality

 

Women’s Health

  • Nutritional and lifestyle factors influencing fertility

  • Mental health issues related to pregnancy

  • Novel care approaches in obstetrics and gynecology

  • IVF techniques and quality management

  • Core ethical principles in assisted reproductive medicine

 

Children’s Health

  • Neonatal and perinatal medicine

  • Newborns’ genomic screening strategies 

  • Precision medicine in pediatrics

  • Mental health for children

  • Pediatric Endocrinology

  • Well Child Care in community settings

 

 

Registration Policy

 

Contact

Please contact education@uschinahealthsummit.org for enquiries and registrations.

 

Invitation Letter

The invitation letter will be provided after we receive full payments. Please note that we cannot contact the U.S. Embassy or General Consulate on behalf of our participants, and we are not in a position to influence visa application processes.

 

Cancellation

We only accept cancellation notices in writing. Cancellations before 8 March 2019 will be refunded with an administrative fee of $50. Cancellations after 8 March 2019 are not refundable.

 

Attendee Replacement

Attendee replacement requests submitted prior 8 March 2019 will be accepted for free. An administrative fee of $150 will be incurred after this date.

 

 

 

Program Information

Program Dates

May 15-18, 2019

Training Fees

5900 USD / person 

Teaching Format

Location

All classes take place at the Harvard Medical School Department of Population Medicine / Harvard Pilgrim Health Care Institute.

Learning formats include lectures, case studies, in-class discussions, and visits to Harvard-affiliated teaching hospitals.

Teaching Faculty

This program is taught by world-renowned faculties and clinical experts within Harvard Medical School and affiliated teaching hospitals, including the following: 

 

Course Design and Introduction:

  • Jing Ma, MD, Ph.D., Associate Professor and Director, China Program for Health Innovation and Transformation, Department of Population Medicine, Harvard Medical School (HMS)

​​

  • Emily Oken, MD, Professor, Vice Chair, Department of Population Medicine, HMS

 

Reproductive Medicine

  • Alan S. Penzias, MD, Boston IVF Center, Director, Fellowship Program in Reproductive Endocrinology and infertility, Associate Professor of OBGYN and Reproductive Biology, HMS

​​

  • Anjali Kaimal, M.D., Obstetrical Director, Multidisciplinary Fetal Care Group, Massachusetts General Hospital (MGH)

​​

  • Brent Barrett, Ph.D., HCLD, Chief Laboratory Director, Boston IVF Center

​​

  • John Petrozza- Division Director of Reproductive Endocrinology, MGH

​​

  • Malavika Prabhu, MD, Instructor in Obstetrics, Gynecology and Reproductive Biology, MGH

​​

  • Mark Clapp, MD, Clinical Fellow in Obstetrics, Gynecology and Reproductive Biology, MGH

​​

  • Michael Alper, MD, Medical Director & President, Boston IVF Center, Associate Clinical Professor OBGYN, HMS

 

Prenatal and Postnatal Care

  • Lee Cohen, Director, Ammon-Pinizzotto Center for Women’s Mental Health Perinatal and Reproductive Psychiatry Clinical Research Program, MGH; Professor of Psychiatry, HMS

  • Marie-France Hivert,Associate Professor, Department of Population Medicine, HMS

 

Pediatrics

  • Ann Chen Wu, MD, MPH, Associate of Population Medicine, Department of Population Medicine, HMS

​​

  • Alison Galbraith, MD, MPH, Associate Professor, Department of Population Medicine, HMS

​​

  • Daniel Slater, MD, Chair of Pediatrics, Atrius Health

​​

  • Endocrinologist of Boston Children’s Hospital

 

Social and Ethical Issues

  • Christine Lu, Associate Professor, Department of Population Medicine, MGH

​​

  • Jorge Chavarro, Associate Professor, Harvard T.H. Chan School of Public Health (HSPH)

​​

  • Louise King, Director, Reproductive Ethics, Center for Bioethics, HMS

 

Leadership

  • Leonard Marcus, Founding Director, Program for Health Care Negotiation and Conflict Resolution, HSPH